Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial

MLA

Fudim, Marat, et al. “Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.” JAMA Cardiology, vol. 9, no. 12, Dec. 2024, pp. 1143–53. EBSCOhost, https://doi.org/10.1001/jamacardio.2024.2612.

APA

Fudim, M., Borlaug, B. A., Mohan, R. C., Price, M. J., Fail, P., Goyal, P., Hummel, S. L., Zirakashvili, T., Shaburishvili, T., Patel, R. B., Reddy, V. Y., Nielsen, C. D., Chetcuti, S. J., Sukul, D., Gulati, R., Kim, L., Benzuly, K., Mitter, S. S., Klein, L., … Shah, S. J. (2024). Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial. JAMA Cardiology, 9(12), 1143–1153. https://doi.org/10.1001/jamacardio.2024.2612

Chicago

Fudim, Marat, Barry A. Borlaug, Rajeev C. Mohan, Matthew J. Price, Peter Fail, Parag Goyal, Scott L. Hummel, et al. 2024. “Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.” JAMA Cardiology 9 (12): 1143–53. doi:10.1001/jamacardio.2024.2612.